EXCHANGE AGREEMENTExchange Agreement • September 2nd, 2020 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
THIS EXCHANGE AGREEMENT (this “Agreement”) is executed as of September 1, 2020 by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Holder”).
STOCK PLAN AGREEMENT FOR PAYMENT OF CONSULTING SERVICESStock Plan Agreement • September 2nd, 2020 • Jaguar Health, Inc. • Pharmaceutical preparations • Delaware
The Investor shall use its reasonable best efforts to comment upon any prospectus within two (2) business days from the date the Investor receives the final pre-filing version of such prospectus.
GLOBAL AMENDMENTGlobal Amendment • September 2nd, 2020 • Jaguar Health, Inc. • Pharmaceutical preparations
This Global Amendment (this “Amendment”) is entered into as of September 1, 2020 by and among Chicago Venture Partners, L.P., a Utah limited partnership (“Lender”), Napo Pharmaceuticals, Inc., a Delaware corporation (“Napo”), and Jaguar Health, Inc., a Delaware corporation (“Jaguar”, and together with Napo, “Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
